Hung Fu Tseng1, Margaret Chi2, Peggy Hung2, Rafael Harpaz3, D Scott Schmid3, Philip LaRussa4, Lina S Sy2, Yi Luo2, Kimberly Holmquist2, Harpreet Takhar2, Steven J Jacobsen2. 1. Department of Research Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA. Electronic address: Hung-Fu.x.Tseng@kp.org. 2. Department of Research Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA. 3. Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA. 4. Department of Pediatrics, College of Physicians and Surgeons, Columbia University, New York City, NY, USA.
Abstract
BACKGROUND: Studies have investigated a possible association between family history of HZ and the occurrence of HZ. However, the results were inconclusive and susceptible to bias. We evaluated this association in an elderly population. METHODS: The matched case-control study conducted at Kaiser Permanente Southern California in 2012-2015 included 656 incident HZ patients ≥60 whose skin lesion tested positive for varicella zoster virus by polymerase chain reaction. Half of the HZ patients were vaccinated with zoster vaccine as achieved by stratified sampling. The controls were randomly selected and 1:1 matched to the cases on sex, age (±1year), and zoster vaccination (±3 months of the case's vaccination date). Conditional logistic regression was used to estimate the odds ratio (OR) and 95% confidence interval (CI). RESULTS: Having any blood relative with a history of HZ was associated with a slightly increased risk of HZ (adjusted OR=1.37, 95% CI 1.05-1.79). The adjusted OR associated with having one and two categories of first-degree blood relatives with a history of HZ was 1.30 (95% CI: 0.97-1.73) and 2.53 (95% CI: 1.17-5.44), respectively. CONCLUSIONS: Our results suggested a weak association between the development of HZ and a positive family history of HZ among the elderly population.
BACKGROUND: Studies have investigated a possible association between family history of HZ and the occurrence of HZ. However, the results were inconclusive and susceptible to bias. We evaluated this association in an elderly population. METHODS: The matched case-control study conducted at Kaiser Permanente Southern California in 2012-2015 included 656 incident HZ patients ≥60 whose skin lesion tested positive for varicella zoster virus by polymerase chain reaction. Half of the HZ patients were vaccinated with zoster vaccine as achieved by stratified sampling. The controls were randomly selected and 1:1 matched to the cases on sex, age (±1year), and zoster vaccination (±3 months of the case's vaccination date). Conditional logistic regression was used to estimate the odds ratio (OR) and 95% confidence interval (CI). RESULTS: Having any blood relative with a history of HZ was associated with a slightly increased risk of HZ (adjusted OR=1.37, 95% CI 1.05-1.79). The adjusted OR associated with having one and two categories of first-degree blood relatives with a history of HZ was 1.30 (95% CI: 0.97-1.73) and 2.53 (95% CI: 1.17-5.44), respectively. CONCLUSIONS: Our results suggested a weak association between the development of HZ and a positive family history of HZ among the elderly population.
Authors: Paul O Hernandez; Saba Javed; Natalia Mendoza; Whitney Lapolla; Lindsey D Hicks; Stephen K Tyring Journal: J Clin Virol Date: 2011-09-15 Impact factor: 3.168
Authors: Stephen F Derose; Richard Contreras; Karen J Coleman; Corinna Koebnick; Steven J Jacobsen Journal: Med Care Res Rev Date: 2012-11-20 Impact factor: 3.929
Authors: Hung Fu Tseng; Ning Smith; Rafael Harpaz; Stephanie R Bialek; Lina S Sy; Steven J Jacobsen Journal: JAMA Date: 2011-01-12 Impact factor: 56.272
Authors: Matthew A Wozniak; Suzanne J Shipley; Curtis B Dobson; Simon P Parker; Fiona T Scott; Mary Leedham-Green; Judy Breuer; Ruth F Itzhaki Journal: Eur J Hum Genet Date: 2007-03-14 Impact factor: 4.246
Authors: Corinna Koebnick; Annette M Langer-Gould; Michael K Gould; Chun R Chao; Rajan L Iyer; Ning Smith; Wansu Chen; Steven J Jacobsen Journal: Perm J Date: 2012
Authors: D R Crosslin; D S Carrell; A Burt; D S Kim; J G Underwood; D S Hanna; B A Comstock; E Baldwin; M de Andrade; I J Kullo; G Tromp; H Kuivaniemi; K M Borthwick; C A McCarty; P L Peissig; K F Doheny; E Pugh; A Kho; J Pacheco; M G Hayes; M D Ritchie; S S Verma; G Armstrong; S Stallings; J C Denny; R J Carroll; D C Crawford; P K Crane; S Mukherjee; E Bottinger; R Li; B Keating; D B Mirel; C S Carlson; J B Harley; E B Larson; G P Jarvik Journal: Genes Immun Date: 2014-10-09 Impact factor: 2.676
Authors: Nancy J Jensen; Daniel P Depledge; Terry Fei Fan Ng; Jessica Leung; Mark Quinlivan; Kay W Radford; Jennifer Folster; Hung-Fu Tseng; Philip LaRussa; Steven J Jacobsen; Judith Breuer; D Scott Schmid Journal: Virology Date: 2020-04-04 Impact factor: 3.513